Notice of NIAID's Participation in PA-14-308 "Platform Delivery Technologies for Nucleic Acid Therapeutics (R41/R42)"

Notice Number:

NOT-AI-15-003

Key Dates

Release Date: October 15, 2014

Related Announcements

PA-14-308

Issued by

National Institute of Allergy and Infectious Diseases (NIAID)

Purpose

The purpose of this Notice is to inform potential applicants of National Institute of Allergy and Infectious Diseases (NIAID's) participation, effective immediately, in the Funding Opportunity Announcement (FOA), PA-14-308, entitled "Platform Delivery Technologies for Nucleic Acid Therapeutics (R41/R42)".

PA-14-308 has been updated in the following ways to reflect NIAID's participation in this FOA.

Part 1. Overview Information

Components of Participating Organizations
National Center for Advancing Translational Sciences (NCATS)
National Institute on Drug Abuse (NIDA)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
National Institute of Allergy and Infectious Diseases (NIAID)

Catalog of Federal Domestic Assistance (CFDA) Number(s):  93.856, 93.855

Part 2. Section VII. Agency Contacts

Scientific/Research Contact(s)
Kailash Gupta, Ph.D. 
National Institute of Allergy and Infectious Diseases (NIAID)
Telephone: 240-627-3207
Email: [email protected]

Financial/Grants Management Contact(s)
Ann Devine
National Institute of Allergy and Infectious Diseases (NIAID)
Telephone: 240-669-2988
Email: [email protected]

All other aspects of the FOA remain the same.

Inquiries

Please direct all inquiries to:

Kailash Gupta, Ph.D. 
National Institute of Allergy and Infectious Diseases (NIAID)
Telephone: 240-627-3207
Email: [email protected]